Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo (Q84057525)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2012

edit

Language	Label	Description	Also known as
English	Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo	scientific article published on 01 May 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

title

Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

author name string

Kirsten Dettmar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Isabell Seitz-Merwald

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Carsten Lindemann

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Petra Schroeder

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Diane Seimetz

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Judith Atz

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

publication date

1 May 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

published in

Clinical and Translational Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

volume

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

page(s)

376-381

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

cites work

Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nuances of lymphocytopenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signaling in leukocyte transendothelial migration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Test system for trifunctional antibodies in 3D MCTS culture

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of an EpCAM/CD3-bispecific BiTE antibody during long-term treatment of mice in the absence of T-cell anergy and sustained cytokine release

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Migration of T cells in vivo: molecular mechanisms and clinical implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22551544

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S12094-012-0811-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Dimensions Publication ID

1040166982

0 references

PubMed publication ID

22551544

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22551544

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551544%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84057525&oldid=2221513526"